Business
Sarepta Therapeutics said Monday evening it will pause all shipments of Elevidys, its gene therapy for Duchenne muscular dystrophy, following a request by the Food and Drug Administration.
Its a sur? [+421 chars]
Leave A Comment
Comments
No comments yet. Be the first to comment!
